Security key
29664W105
- Type / Class
- Equity / COM
- Shares outstanding
- 258,506,508
- Total 13F shares
- 126,046,299
- Share change
- +573,940
- Total reported value
- $277,285,420
- Put/Call ratio
- 83%
- Price per share
- $2.20
- Number of holders
- 188
- Value change
- +$4,393,183
- Number of buys
- 76
- Number of sells
- 68
Report period
Q4 2024
Institutions
188
Top holders
10
ESPR full security history
Newer quarter: Q1 2025
Previous quarter: Q3 2024
Esperion Therapeutics, Inc. SEC filings
Esperion Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 29664W105
Recent filing periods:
Top shareholders of ESPR - Esperion Therapeutics, Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WASATCH ADVISORS LP |
13F
|
Company |
9%
|
23,346,013
|
$38,520,921 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
5.5%
|
14,264,975
|
$23,537,209 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
5%
|
13,043,077
|
$21,521,077 | — | 30 Sep 2024 | |
| Bellevue Group AG |
13F
|
Company |
3.8%
|
9,944,064
|
$16,407,706 | — | 30 Sep 2024 | |
| Two Seas Capital LP |
13F
|
Company |
2.5%
|
6,584,278
|
$10,864,059 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
4,331,314
|
$7,147,816 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.5%
|
3,854,314
|
$6,359,618 | — | 30 Sep 2024 | |
| Meditor Group Ltd |
13F
|
Company |
1.5%
|
3,791,300
|
$6,255,645 | — | 30 Sep 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1.4%
|
3,625,059
|
$5,981,347 | — | 30 Sep 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1.4%
|
3,600,100
|
$5,940,165 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.3%
|
3,403,530
|
$5,615,824 | — | 30 Sep 2024 | |
| CenterBook Partners LP |
13F
|
Company |
1.2%
|
3,112,585
|
$5,135,765 | — | 30 Sep 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1.2%
|
3,092,629
|
$5,102,839 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1%
|
2,646,199
|
$4,366,229 | — | 30 Sep 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.87%
|
2,244,360
|
$3,703,194 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.81%
|
2,099,010
|
$3,463,366 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.8%
|
2,069,117
|
$3,414,044 | — | 30 Sep 2024 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
0.76%
|
1,975,000
|
$3,258,750 | — | 30 Sep 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.6%
|
1,560,072
|
$2,574,119 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.57%
|
1,474,422
|
$2,432,797 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.51%
|
1,307,668
|
$2,157,652 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.43%
|
1,123,552
|
$1,853,862 | — | 30 Sep 2024 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.42%
|
1,092,862
|
$1,803,222 | — | 30 Sep 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.35%
|
914,100
|
$1,508,265 | — | 30 Sep 2024 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.35%
|
903,140
|
$1,490,181 | — | 30 Sep 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.29%
|
756,027
|
$1,247,445 | — | 30 Sep 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.29%
|
750,784
|
$1,238,794 | — | 30 Sep 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.28%
|
711,278
|
$1,173,609 | — | 30 Sep 2024 | |
| Diametric Capital, LP |
13F
|
Company |
0.26%
|
666,839
|
$1,100,284 | — | 30 Sep 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.23%
|
602,936
|
$994,845 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.21%
|
554,914
|
$915,608 | — | 30 Sep 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.2%
|
518,100
|
$854,865 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.16%
|
425,774
|
$702,527 | — | 30 Sep 2024 | |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO |
13F
|
Company |
0.14%
|
367,373
|
$606,165 | — | 30 Sep 2024 | |
| Anson Funds Management LP |
13F
|
Company |
0.13%
|
327,110
|
$539,732 | — | 30 Sep 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.12%
|
309,671
|
$510,958 | — | 30 Sep 2024 | |
| PINNACLE ASSOCIATES LTD |
13F
|
Company |
0.11%
|
283,255
|
$846,932 | — | 30 Sep 2024 | |
| Marex Group plc |
13F
|
Company |
0.11%
|
275,000
|
$453,750 | — | 30 Sep 2024 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.1%
|
262,134
|
$433,000 | — | 30 Sep 2024 | |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.1%
|
254,265
|
$419,537 | — | 30 Sep 2024 | |
| Parallel Advisors, LLC |
13F
|
Company |
0.09%
|
244,000
|
$402,600 | — | 30 Sep 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.09%
|
243,090
|
$401,092 | — | 30 Sep 2024 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.09%
|
242,847
|
$400,698 | — | 30 Sep 2024 | |
| Graham Capital Management, L.P. |
13F
|
Company |
0.09%
|
237,563
|
$391,979 | — | 30 Sep 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.09%
|
229,330
|
$378,395 | — | 30 Sep 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.09%
|
222,786
|
$367,597 | — | 30 Sep 2024 | |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP |
13F
|
Company |
0.09%
|
222,482
|
$367,095 | — | 30 Sep 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.08%
|
210,222
|
$346,866 | — | 30 Sep 2024 | |
| NJ State Employees Deferred Compensation Plan |
13F
|
Company |
0.08%
|
195,125
|
$321,956 | — | 30 Sep 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.07%
|
183,651
|
$303,024 | — | 30 Sep 2024 |
Institutional Holders of Esperion Therapeutics, Inc. - COM (ESPR) as of Q4 2024
As of 31 Dec 2024,
Esperion Therapeutics, Inc. - COM (ESPR) was held by
188 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
126,046,299 shares.
The largest 10 holders included
WASATCH ADVISORS LP, BlackRock, Inc., VANGUARD GROUP INC, Bellevue Group AG, MORGAN STANLEY, Two Seas Capital LP, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA ADVISERS, LP, and TWO SIGMA INVESTMENTS, LP.
This page lists
189
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
181
Q4 2024 holders
188
Holder diff
7
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.